Elizabeth Betz
Family · Brownsville, TXNPI 1942572771
Payments from drug & device makers
Across 536 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- Lilly USA, LLC$1K
- Amgen$1K
- Merck$483
- Novartis$435
- Amarin Pharma, Inc.$365
- plus $3K from 29 others
What the payments were for
- Food & beverage$8,16299%
- Education$781%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 137 | $1,503 |
| Lilly USA, LLC | 91 | $1,400 |
| Amgen | 88 | $1,079 |
| Merck | 29 | $483 |
| Novartis | 31 | $435 |
| Amarin Pharma, Inc. | 24 | $365 |
| Mannkind Corporation | 9 | $342 |
| AstraZeneca | 9 | $315 |
| Astellas Pharma US Inc | 13 | $242 |
| Insulet Corporation | 11 | $233 |
| Bayer | 14 | $215 |
| AbbVie | 17 | $214 |
| Johnson & Johnson | 5 | $194 |
| Dexcom, Inc. | 8 | $147 |
| Pfizer | 9 | $141 |
| Mayne Pharma Commercial LLC | 1 | $125 |
| GSK | 6 | $115 |
| Exact Sciences | 6 | $113 |
| Boehringer Ingelheim | 5 | $94 |
| Biotronik Inc. | 2 | $89 |
| Cardiovascular Systems Inc. | 1 | $68 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $58 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Lexicon Pharmaceuticals, Inc. | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $23 |
| Abbott | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Madrigal Pharmaceuticals | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Vifor Pharma, Inc. | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,239 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 142 | $186,525 |
| MounjaroTirzepatide | 109 | $153,837 |
| FarxigaDapagliflozin Propanediol | 83 | $97,633 |
| JardianceEmpagliflozin | 46 | $69,280 |
| VascepaIcosapent Ethyl | 65 | $52,286 |
| RybelsusSemaglutide | 23 | $47,468 |
| ProliaDenosumab | 26 | $43,201 |
| MyrbetriqMirabegron | 35 | $36,971 |
| TradjentaLinagliptin | 33 | $35,000 |
| LinzessLinaclotide | 40 | $34,359 |
| TrulicityDulaglutide | 21 | $27,918 |
| KerendiaFinerenone | 21 | $26,967 |
| Icosapent Ethyl | 43 | $20,313 |
| GemtesaVibegron | 17 | $19,391 |
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 16 | $15,974 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,503 | $233,994165 claims |
| Lilly USA, LLCMounjaro, Trulicity | $1,400 | $181,756130 claims |
| Boehringer IngelheimJardiance, Tradjenta | $94 | $104,28079 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $315 | $103,31194 claims |
| AmgenProlia | $1,079 | $43,20126 claims |
| Astellas Pharma US IncMyrbetriq | $242 | $36,97135 claims |
| AbbVieLinzess | $214 | $34,35940 claims |
| BayerKerendia | $215 | $26,96721 claims |
| MerckJanuvia, Lagevrio (Eua) | $483 | $25,16024 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $20 | $19,39117 claims |
| PfizerPaxlovid | $141 | $1,42921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.
Other family in Brownsville
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.